Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
TransCode Therapeutics Inc (NASDAQ: RNAZ) closed the day trading at $3.92 down -37.93% from the previous closing price of $6.32. In other words, the price has decreased by -$37.93 from its previous closing price. On the day, 0.85 million shares were traded. RNAZ stock price reached its highest trading level at $4.1999 during the session, while it also had its lowest trading level at $3.21.
Ratios:
For a better understanding of RNAZ, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.58 and its Current Ratio is at 1.58. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RNAZ now has a Market Capitalization of 2729296 and an Enterprise Value of 2737839.
Stock Price History:
Over the past 52 weeks, RNAZ has reached a high of $264.00, while it has fallen to a 52-week low of $6.31. The 50-Day Moving Average of the stock is -72.37%, while the 200-Day Moving Average is calculated to be -80.98%.
Shares Statistics:
Over the past 3-months, RNAZ traded about 47.66K shares per day on average, while over the past 10 days, RNAZ traded about 38750 shares per day. A total of 0.70M shares are outstanding, with a floating share count of 0.70M. Insiders hold about 0.16% of the company’s shares, while institutions hold 1.42% stake in the company. Shares short for RNAZ as of 1730332800 were 743584 with a Short Ratio of 0.39, compared to 1727654400 on 1382893. Therefore, it implies a Short% of Shares Outstanding of 743584 and a Short% of Float of 4.31.